DW-2008

N/A

Report date: 2022/08/25 11:28:26

Base Information

Drug NameDW-2008
Drug Alias NameDW-2008DW-2008S
ClassificationBiologicsNatural product/Extract > Plants extract
Mechanisms of ActionTh2 cells inhibitorsT cell immunoglobulin and ITIM domains inhibitors
TargetsT cell immunoglobulin and ITIM domains
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Rhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDong Wha Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDong Wha Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Rhinitis, AllergicAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A